A circulating T-cell differentiation marker to predict response to immune checkpoint inhibitors
Yamauchi et al.
bioRxiv
June 2020
Authors and Affiliates
Takayoshi Yamauchi1 , Toshifumi Hoki1 , Takaaki Oba1 , Vaibhav Jain1 , Hongbin Chen1, Kristopher Attwood4 , Sebastiano Battaglia1,5, Saby George2,3, Gurkamal Chatta2 , Igor Puzanov2, Carl Morrison6 , Kunle Odunsi1,7,8, Brahm H. Segal2,3,8, Grace K. Dy2, Marc S. Ernstoff2,3 , Fumito Ito1,8,9,10* Center for Immunotherapy, Roswell Park Comprehensive Cancer Center, Buffalo, NY 2 Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York 3 Department of Medicine, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, the State University of New York, Buffalo, NY 4 Department of Biostatistics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 5 Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 6 Department of Pathology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 7 Department of Gynecologic Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 8 Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 9 Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 10 Department of Surgery, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, the State University of New York, Buffalo, NY